BEST MED ANTO LIMITED

Company Registration Number:
10880761 (England and Wales)

Unaudited micro entity accounts for the year ended 31 July 2023

Period of accounts

Start date: 01 August 2022

End date: 31 July 2023

BEST MED ANTO LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2023

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

BEST MED ANTO LIMITED

Company Information

for the Period Ended 31 July 2023




Registered office: 84
Albert Road
2 Lakeside
Cheltenham
England
GL52 2RD
Company Registration Number: 10880761 (England and Wales)

BEST MED ANTO LIMITED

Balance sheet

As at 31 July 2023


2023
£

2022
£
Called up share capital not paid: 1 1
Current assets: 10,307 12,101
Net current assets (liabilities): 10,307 12,101
Total assets less current liabilities: 10,308 12,102
Total net assets (liabilities): 10,308 12,102
Capital and reserves: 10,308 12,102

BEST MED ANTO LIMITED

Balance sheet continued

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 12 February 2024
And Signed On Behalf Of The Board By:

Name: Constantin-Ciprian SUDITU
Status: Director

Name: Mihaela- Elena SUDITU
Status: Director

The notes form part of these financial statements

BEST MED ANTO LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 July 2023

  • 1. Employee Information

    Average number of employees: 3

BEST MED ANTO LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 July 2023

  • 2. Off balance sheet disclosure

    No